This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

SleepMed And Watermark Medical Merge To Deliver Integrated Sleep Care Management To Millions Of Americans Suffering From Sleep Disorders

The new SleepMed's leadership team is a blend of executives from both companies. John Sculley, the former CEO of Pepsico and Apple, will serve as Chairman of the Board.  Dr. Richard Bogan will serve as the Director and Chief Medical Officer and Sean Heyniger and David Lewis will serve as CEO and President, respectively. Dr. Philip Westbrook, co-founder of the AASM and National Sleep Foundation, will serve as director of QA and Compliance.

About SleepMedSleepMed was formed in December 1999 through the merger of Sleep Disorder Centers of America (SDCA), based in Columbia, SC, and DigiTrace Care Services, Inc. (DCSI), based in Boston, MA. SDCA was founded in 1994 by David Lewis and Dr. Richard Bogan, who has board certifications in sleep medicine, pulmonary medicine, critical care medicine and internal medicine.

About Watermark MedicalWatermark Medical, Inc. is a privately held healthcare information technology company formed in 2008 focused on improving the clinical outcomes of patients with chronic diseases.  Watermark pioneered cloud-based home sleep testing for obstructive sleep apnea by allowing primary care physicians to become the point of care for diagnostic testing.  Its co-founders have a track record of building successful information technology companies and sales channels for the healthcare services sector. Watermark has a national direct sales force of more than 25 sales representatives covering all 50 states and approximately 2,000 distribution sales representatives. 

CONTACT: Jennifer HarringtonHavas PR(610) 574-9196 Jennifer.Harrington@havasww.com

SOURCE SleepMed, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,702.85 -55.06 -0.31%
S&P 500 2,073.47 -3.95 -0.19%
NASDAQ 4,995.5510 -17.5720 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs